AU5271693A - 2,4-substituted 5-(N-substituted sulfamoyl) benzoylguanidines, process for their preparation, their use as drugs or diagnostic agents, and drugs in which they are present - Google Patents

2,4-substituted 5-(N-substituted sulfamoyl) benzoylguanidines, process for their preparation, their use as drugs or diagnostic agents, and drugs in which they are present

Info

Publication number
AU5271693A
AU5271693A AU52716/93A AU5271693A AU5271693A AU 5271693 A AU5271693 A AU 5271693A AU 52716/93 A AU52716/93 A AU 52716/93A AU 5271693 A AU5271693 A AU 5271693A AU 5271693 A AU5271693 A AU 5271693A
Authority
AU
Australia
Prior art keywords
drugs
substituted
benzoylguanidines
preparation
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52716/93A
Inventor
Udo Albus
Hans-Jochen Lang
Jacques Mauger
Wolfgang Scholz
Andreas Weichert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU5271693A publication Critical patent/AU5271693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/64—X and Y being nitrogen atoms, e.g. N-sulfonylguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AU52716/93A 1992-12-28 1993-12-23 2,4-substituted 5-(N-substituted sulfamoyl) benzoylguanidines, process for their preparation, their use as drugs or diagnostic agents, and drugs in which they are present Abandoned AU5271693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4244318 1992-12-28
DE4244318 1992-12-28

Publications (1)

Publication Number Publication Date
AU5271693A true AU5271693A (en) 1994-07-07

Family

ID=6476700

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52716/93A Abandoned AU5271693A (en) 1992-12-28 1993-12-23 2,4-substituted 5-(N-substituted sulfamoyl) benzoylguanidines, process for their preparation, their use as drugs or diagnostic agents, and drugs in which they are present

Country Status (7)

Country Link
EP (1) EP0604852A1 (en)
JP (1) JPH06234730A (en)
AU (1) AU5271693A (en)
CA (1) CA2112194A1 (en)
FI (1) FI935825A (en)
HU (1) HU9303749D0 (en)
NO (1) NO934836L (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672246B2 (en) * 1992-12-15 1996-09-26 Hoechst Aktiengesellschaft Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
US5708034A (en) * 1995-11-03 1998-01-13 Hoechst Aktiengesellschaft Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
US5731350A (en) * 1995-11-20 1998-03-24 Hoechst Aktiengesellschaft Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
US5747541A (en) * 1995-09-27 1998-05-05 Hoechst Aktiengesellschaft Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them
US5811448A (en) * 1995-12-14 1998-09-22 Hoechst Aktiengesellschaft Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof
US5856344A (en) * 1995-11-14 1999-01-05 Hoechst Aktiengesellschaft Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (en) 1993-08-24 1995-03-02 Hoechst Ag Substituted N, N'-di-benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
IL114670A0 (en) * 1994-08-05 1995-11-27 Fujisawa Pharmaceutical Co Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DE4430213A1 (en) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4432105A1 (en) * 1994-09-09 1996-03-14 Hoechst Ag Fluoro-alkyl / alkenyl-substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
ATE185557T1 (en) * 1995-01-30 1999-10-15 Hoechst Ag BASIC-SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICATION OR DIAGNOSTIC AND THE MEDICATION CONTAINING THEM
US6057322A (en) * 1995-01-30 2000-05-02 Hoechst Aktiengesellschaft Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them
DE19529612A1 (en) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl or sulfinyl benzoylguanidine derivatives
DE19603425A1 (en) * 1996-01-31 1997-08-07 Hoechst Ag Substituted diaryldicarboxylic acid diguanidides, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
JPH09291076A (en) * 1996-04-24 1997-11-11 Sumitomo Pharmaceut Co Ltd Substituted guanidine derivative and its production
BE1012386A3 (en) * 1999-01-15 2000-10-03 Univ Liege SULFONAMIDES benzene DERIVATIVES AND USES THEREOF.
DE19951418A1 (en) * 1999-10-26 2001-05-03 Merck Patent Gmbh Process for the preparation of N- (4,5-bismethanesulfonyl-2-methyl-benzoyl) guanidine, hydrochloride
DE10060809A1 (en) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Substituted anthranilic acids, their use as medicaments or diagnostic agents, as well as medicaments containing them, and a combined pharmaceutical preparation with a sodium / hydrogen exchange (NHE) blocker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (en) * 1989-09-06 1991-03-07 Hoechst Ag BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672246B2 (en) * 1992-12-15 1996-09-26 Hoechst Aktiengesellschaft Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
US5747541A (en) * 1995-09-27 1998-05-05 Hoechst Aktiengesellschaft Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them
US5708034A (en) * 1995-11-03 1998-01-13 Hoechst Aktiengesellschaft Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
US5856344A (en) * 1995-11-14 1999-01-05 Hoechst Aktiengesellschaft Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them
US5731350A (en) * 1995-11-20 1998-03-24 Hoechst Aktiengesellschaft Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
US5811448A (en) * 1995-12-14 1998-09-22 Hoechst Aktiengesellschaft Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof

Also Published As

Publication number Publication date
FI935825A0 (en) 1993-12-23
NO934836D0 (en) 1993-12-27
HU9303749D0 (en) 1994-04-28
FI935825A (en) 1994-06-29
EP0604852A1 (en) 1994-07-06
NO934836L (en) 1994-06-29
CA2112194A1 (en) 1994-06-29
JPH06234730A (en) 1994-08-23

Similar Documents

Publication Publication Date Title
AU5271693A (en) 2,4-substituted 5-(N-substituted sulfamoyl) benzoylguanidines, process for their preparation, their use as drugs or diagnostic agents, and drugs in which they are present
AU628696B2 (en) Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HU9503609D0 (en) Arylacetamides, process for their preparation, compositions containing them and their use as fungicides
AU7428591A (en) 3,5-disubstituted 2-isoxazolines and isoxazoles, processes for their preparation, agents containing them and their use
AU661017B2 (en) N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
IL108502A (en) 4-benzoylisoxazole derivatives, processes for their preparation and herbicidal compositions containing them
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
AU678208B2 (en) 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
IL108800A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
HU9401691D0 (en) 2-oximino-2-phenyl-acetamide derivatives, process for their preparation, their use and fungicidal compositions containing them
IL110480A0 (en) Methylguanidine derivatives, their preparation and pharmaceutical compositions containing them
AU8146994A (en) Novel taxicine derivatives, their preparation and pharmaceutical compositions containing them
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL105774A (en) N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them
HU9403633D0 (en) 5-(1,2,4-+triazol-1-yl-methyl)-3h-iso-benzofuran-1-one derivatives, their preparation and use as aromatase inhibitors
AU3155497A (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
HUP9900079A3 (en) 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms